>>Description of the research protocol

Prevention of post-ERCP acute pancreatitis by heme-oxygenase activation through the administration of hemin : a prospective, randomized double blind controlled trial.
Phase III study| Status : Ongoing and recruiting

Additional details

Indication (or studied pathology) : Pancréas
Brugmann identifier : NA
EudraCT identifier : 2011-000397-59


Involved department : Gastroenterology
Principal investigator : Debroux
Sponsor : Erasme
Contact : Clinical Research Unit

>This protocol was approved by the Erasme ethics committee.